Voluntary recall of SYMJEPI epinephrine injection in the US for potential manufacturing defect News item 02 April 2022 Pages: 3 - 3
Best regimen for elexacaftor/ivacaftor/tezacaftor with nirmatrelvir-ritonavir for COVID-19? Clinical study 02 April 2022 Pages: 4 - 4
Concomitant tizanidine and ciprofloxacin increases risk of hypotension Unknown 02 April 2022 Pages: 5 - 5
Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients Unknown 02 April 2022 Pages: 6 - 6
Different safety profiles for SGLT-2 vs SGLT-1/2 inhibitors for T2DM Unknown 02 April 2022 Pages: 7 - 7
Dupiliumab-related ocular AEs in patients with atopic dermatitis Clinical study 02 April 2022 Pages: 8 - 8
Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine Clinical study 02 April 2022 Pages: 10 - 10
No safety signal after COVID-19 vaccination for immune-mediated neurological events Clinical study 02 April 2022 Pages: 11 - 11
Sodium channel-blocking anticonvulsants do not increase risk of cardiac arrest Clinical study 02 April 2022 Pages: 12 - 12